SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-157530
Filing Date
2022-05-23
Accepted
2022-05-23 16:39:33
Documents
13
Period of Report
2022-05-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d306255d8k.htm   iXBRL 8-K 28857
2 EX-3.1 d306255dex31.htm EX-3.1 6684
  Complete submission text file 0001193125-22-157530.txt   164264

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cala-20220523.xsd EX-101.SCH 2864
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cala-20220523_lab.xml EX-101.LAB 18741
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cala-20220523_pre.xml EX-101.PRE 11713
7 EXTRACTED XBRL INSTANCE DOCUMENT d306255d8k_htm.xml XML 3568
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36644 | Film No.: 22952303
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences